Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea-Reference-Cited by-同舟云学术

Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea

Published:2020-05-02 Issue:6 Volume:36 Page:993-1002
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Kim Do Young¹,Wong Gabriel²,Lee Janet²,Kim Myung Hwa³,Smith Nathaniel⁴^ORCID,Blissett Rob⁴,Kim Hyung Joon⁵

Affiliation:

1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

2. Gilead Sciences Inc, Foster City, CA, USA

3. Gilead Sciences Korea Ltd, Seoul, South Korea

4. Maple Health Group LLC, New York, NY, USA

5. Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Korea

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1756232

Reference54 articles.

1. Jang ES. The Nationwide Seroprevalence of Anti-HCV Is Decreasing from 2009 to 2015 in South Korea. in Paper presented at: The liver week 2017; Incheon, Korea. 2017.

2. A nationwide seroepidemiology of hepatitis C virus infection in South Korea

3. Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims' Data

4. The Economic Burden of Hepatitis A, B, and C in South Korea

5. KASL clinical practice guidelines: management of hepatitis C

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study;Clinical and Molecular Hepatology;2023-07-01

2. Hepatitis C virus: A critical approach to who really needs treatment;World Journal of Hepatology;2022-01-27

3. Liver Diseases in South Korea: A Pulse Check of the Public’s Knowledge, Awareness, and Behaviors;Yonsei Medical Journal;2022

4. A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective;Clinical and Molecular Hepatology;2022-01-01

5. Cost-effectiveness of chronic hepatitis C screening and treatment;Clinical and Molecular Hepatology;2021-12-27